Effects of oral glatiramer acetate on clinical and MRI-monitored disease activity in patients with relapsing multiple sclerosis: a multicentre, double-blind, randomised, placebo-controlled study.
about
Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysisGlatiramer acetate for multiple sclerosisSuppression of ongoing experimental allergic encephalomyelitis in DA rats by novel peptide drug, structural part of human myelin basic protein 46-62.Adrenocorticotropic hormone versus methylprednisolone added to interferon β in patients with multiple sclerosis experiencing breakthrough disease: a randomized, rater-blinded trialAssessing changes in relapse rates in multiple sclerosis.Interferon beta and glatiramer acetate therapy.Glatiramer acetate therapy for multiple sclerosis: a review.Neuroprotection with glatiramer acetate: evidence from the PreCISe trial.The Effect of Dimethyl Fumarate on Cerebral Gray Matter Atrophy in Multiple Sclerosis.Glatiramer acetate and the glatiramoid class of immunomodulator drugs in multiple sclerosis: an update.Back to the future for multiple sclerosis therapy: focus on current and emerging disease-modifying therapeutic strategies.MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials.Time-patterns of annualized relapse rates in randomized placebo-controlled clinical trials in relapsing multiple sclerosis: a systematic review and meta-analysis.Immunotherapy of multiple sclerosis: the state of the art.Volumetric Analysis from a Harmonized Multisite Brain MRI Study of a Single Subject with Multiple Sclerosis.The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis.Automated segmentation of cerebral deep gray matter from MRI scans: effect of field strength on sensitivity and reliabilityInfluence of treatment in multiple sclerosis disability: an open, retrospective, non-randomized long-term analysis.Gender effects on intramuscular interferon beta-1a in relapsing-remitting multiple sclerosis: analysis of 1406 patients.Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis.Changes in the metabolome and microRNA levels in biological fluids might represent biomarkers of neurotoxicity: A trimethyltin study.Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month, multicentre, follow-up study.Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.The heritage of glatiramer acetate and its use in multiple sclerosis
P2860
Q24202108-8BF2F0E1-08CF-4626-86E2-8C64ED4FE9E6Q24235498-AE9E1223-C8B2-4FD7-9CBA-8E5BCDCBC736Q33509141-CAA7A100-3945-4CA7-A5F4-28AC0C0738A1Q33589934-AA5CABB4-D185-4653-851A-079CB7FC3FA5Q33681680-14C570BA-C02B-4AC3-BF16-35ADA051027FQ36568660-FDF1348E-6B6B-4C4D-8144-17DB9FB20457Q36662903-B43BF5DB-5181-412B-9D30-15EE7D8F3E0CQ36993507-35A4072F-F9D4-4FFE-BDFC-CDF7ED668D31Q37459099-51DBF25D-9862-4E85-BD24-730CB8B9DFD8Q37732340-5E6417B9-3001-4028-B9CB-B9E1EBC5A0D0Q37773270-828F152C-31B4-4B56-9BBB-055C835EF9DDQ37964985-88E33D62-C4AB-485F-A16C-1762EA9C9C42Q37994162-A8511E24-A621-4B69-B165-ED73A49ADB20Q38083041-F29008F8-FC7A-44DA-BAF6-8BC10CD668E1Q38713119-B7DAF76E-7FBD-4A1B-9E16-22221C49C064Q38761495-F16CB9DB-D27A-4425-A99B-B7FECE9AABCBQ41613266-566E9C5C-DB09-41D6-881C-181963728FF1Q42929708-6C1C4C10-3F44-4914-8822-A1CEC077480CQ44194290-580B77F1-DD14-4F04-AEAD-1C8CFE93D647Q47242221-8E21B1DF-69B1-4519-B663-D04CEF2D80BCQ47654043-468B24A6-39E0-4C97-8823-1D2F9674017BQ48340191-B741D4CE-B840-44BF-828B-116FCD515176Q48343851-2387FC8F-D554-42EB-A38A-7D9E939BE3DDQ56804781-9E112C90-2F9A-4A63-9113-0F35B4989C35
P2860
Effects of oral glatiramer acetate on clinical and MRI-monitored disease activity in patients with relapsing multiple sclerosis: a multicentre, double-blind, randomised, placebo-controlled study.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Effects of oral glatiramer ace ...... sed, placebo-controlled study.
@en
Effects of oral glatiramer ace ...... sed, placebo-controlled study.
@nl
type
label
Effects of oral glatiramer ace ...... sed, placebo-controlled study.
@en
Effects of oral glatiramer ace ...... sed, placebo-controlled study.
@nl
prefLabel
Effects of oral glatiramer ace ...... sed, placebo-controlled study.
@en
Effects of oral glatiramer ace ...... sed, placebo-controlled study.
@nl
P1433
P1476
Effects of oral glatiramer ace ...... sed, placebo-controlled study.
@en
P2093
CORAL Study Group
Jerry S Wolinsky
P304
P356
10.1016/S1474-4422(06)70327-1
P577
2006-03-01T00:00:00Z